Our systematic review excluded Gorlin syndrome, a hereditary cancer syndrome predominantly involving PTCH1 mutations, to avoid skewing the results for non-Gorlin BCC patients [21]. Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.